Sotolasib

Name: Sotolasib
Availability: sotolasib-343793.html

Category:Active Pharmaceutical Ingredients
Product Name:Sotolasib
CAS No.:296729-00-3
Standard:In-house Standards
Price(USD):Negotiable
Company:Shanghai Hope-chem Co.,Ltd.

Send Inquiry

Favorites

Similar Products

Coenzyme Q10

carbomer 974P

Propantheline Bromide

Hydrocortisone

Black Currant Extract

Refined Fish Oil

Basic Info

Grade: pharmaceutical grade

Factory Location: Shanghai

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Sotiracib is an acrylamide derived KRAS inhibitor developed by Anjin Corporation and currently undergoing clinical trials for the treatment of solid tumors with KRAS G12C mutations. This mutation accounts for over 50% of all KRAS mutations. It is the first experimental KRAS inhibitor. The drug [MRTX849] is currently under development and has the same goals

Send your message to this supplier

From:
To:
Shanghai Hope-chem Co.,Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Sotolasib

You may like